Challenges in the management of juvenile idiopathic arthritis with etanercept
Clare E Pain, Liza J McCannAlder Hey Children’s NHS Foundation Trust, Eaton Road, Liverpool, UKAbstract: Biologic agents have been designed with the help of immunological studies to target particular areas of the immune system which are thought to play a role in the pathogenesis of dis...
Guardado en:
Autores principales: | Clare E Pain, Liza J McCann |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://doaj.org/article/064cf087337f4644b211a48895a2b1b1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Safety of etanercept in elderly subjects with rheumatoid arthritis
por: Alfredomaria Lurati, et al.
Publicado: (2009) -
Abatacept in difficult-to-treat juvenile idiopathic arthritis
por: Jasmin B Kuemmerle-Deschner, et al.
Publicado: (2009) -
Long term efficacy and safety of etanercept in the treatment of psoriasis and psoriatic arthritis
por: Kivelevitch D, et al.
Publicado: (2014) -
Biological therapies for the treatment of juvenile idiopathic arthritis: Lessons from the adult and pediatric experiences
por: Matthew L Stoll, et al.
Publicado: (2008) -
JUVENILE ARTHRITIS DISEASE ACTIVITY SCORE IN CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS AND ITS ASSOCIATION WITH CLINICAL DISEASE ACTIVITY IN LAHORE
por: Zanera Nawaz, et al.
Publicado: (2018)